Related Experiment Video
Updated: Jul 9, 2026

Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
Published on: May 12, 2023
Neutrophil extracellular traps biomarkers are associated with lung function obstruction severity in bronchial asthma
Yueyan Mao1, Xiaoping Fan1, Liqing Zhu2
1Department of pediatrics, Zhejiang University School of Medicine Second Affiliated Hospital Linping Hospital, China.
Abstract:
ObjectiveTo explore the value of neutrophil extracellular traps biomarkers (myeloperoxidase and citrullinated histone H3) in patients with bronchial asthma.MethodsA total of 66 patients with bronchial asthma (stratified into mild, moderate, and severe lung function obstruction subgroups according to predicted forced expiratory volume in 1 second) and 60 healthy controls were enrolled. Plasma levels of myeloperoxidase and citrullinated histone H3 were measured. Spearman correlation analysis and receiver operating characteristic curve analysis were used to evaluate correlations and diagnostic performance.ResultsCompared with healthy controls, patients with bronchial asthma had significantly higher plasma levels of myeloperoxidase and citrullinated histone H3 (all p < 0.001). Myeloperoxidase and citrullinated histone H3 levels increased with the severity of lung function obstruction (severe > moderate > mild; all p < 0.05). Receiver operating characteristic analysis showed that the area under the curve for myeloperoxidase and citrullinated histone H3 alone in diagnosing bronchial asthma was 0.824 and 0.867, respectively.ConclusionPlasma myeloperoxidase and citrullinated histone H3 are elevated in patients with bronchila asthma and are closely associated with the severity of lung function obstruction.
More Related Videos
07:36Immunofluorescence Imaging of Neutrophil Extracellular Traps in Human and Mouse Tissues
Published on: August 18, 2023
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Related Concept Videos
Microbiota of the Respiratory Tract
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma I: Introduction
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease II: Emphysema